LISATA THERAPEUTICS, INC. Grants Receivable, Current
LISATA THERAPEUTICS, INC. (LSTA) had Grants Receivable, Current of $5.70 million as of 2017-05-31, per its 10-Q filed 2018-08-09.
Discontinued › Notes › Nontrade Receivables
us-gaap:GrantsReceivableCurrent · last filed 2018-08-09
- 2017-05-31: Grants Receivable, Current $5.70M.
- 2017-05-04: Grants Receivable, Current $5.70M.
| Period end | Grants Receivable, Current |
|---|---|
| 2017-05-31 | $5.70M 10-Q · filed 2018-08-09 |
| 2017-05-04 | $5.70M 10-K · filed 2018-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |